Dr. Kolin Elliott Rubel, MD

Dr. Rubel practices at M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota.

Dr. Rubel's NPI, 1639608102, was assigned on June 8, 2017. Dr. Rubel graduated from Indiana University School Of Medicine in 2017. Dr. Rubel's Tennessee license number on file is 65367.

Dr. Rubel's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis, at 909 Fulton Street Southeast, Minneapolis, MN 55455. The practice phone is (612) 676-5500.

Dr. Rubel's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota. Dr. Rubel is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Rubel to 3 more group practices and clinics and 3 medical groups, each named with a free account. Dr. Rubel's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubel practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rubel's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rubel is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Rubel's licenses on file in 3 states: Tennessee, Minnesota and Indiana.

Dmand AI lists chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Rubel treats.

CMS data shows 266 Medicare services from Dr. Rubel across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $29,219 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Rubel in 2024. The largest group is 65 to 74, with 42 patients. 67% of them have high blood pressure, and 52% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rubel's median patient age at 50, with 55% women.

In 2024, Dr. Rubel wrote 289 Medicare Part D claims for 96 patients. 85% of them were for generic drugs. CMS names the drug for 232 of them, across 6 drugs with 11 or more claims each, at $142,345 in total drug cost. In 2023, CMS named 104 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Rubel for performance year 2024, reported as part of a group. Dr. Rubel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubel as offering telehealth.

Dmand AI links 21 papers to Dr. Rubel, published from 2017 to 2024. 2020 was the busiest year, with 8. The most frequent topics are COVID-19, Pandemics and SARS-CoV-2. Dr. Rubel has published most often in Int Forum Allergy Rhinol. Dr. Rubel's most frequent co-authors are Jonathan Y. Ting, MD, Elisa Anne Illing, MD and Sarah Jo McDaniel Burgin, MD.

CMS Open Payments shows 13 general payments to Dr. Rubel from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 57% of the total. Medtronic, Inc. paid the most, $591.

Dr. Rubel graduated from Indiana University School Of Medicine in 2017.

Dr. Rubel is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.